SUMMER MONROE: Open Payments
NPI 1396018404 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 26 payments from 8 companies in 2025. Trend: 2023 $373 · 2024 $701 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $279 |
| GlaxoSmithKline, LLC. | 5 | $121 |
| Grifols USA, LLC | 1 | $117 |
| Regeneron Healthcare Solutions, Inc. | 5 | $108 |
| Boston Scientific Corporation | 2 | $64 |
| Amgen Inc. | 2 | $46 |
| Optinose US, Inc. | 2 | $39 |
| Stryker Corporation | 1 | $20 |
Products named: DUPIXENT, NUCALA, Prolastin-C Liquid, WATCHMAN FLX, TEZSPIRE, Xhance, AUDION ET DILATION SYSTEM.
Industry payments across FL — which companies pay providers there.
